Clinical relevance of depressive symptom improvement in bipolar I depressed patients

Journal of Affective Disorders

Volumn 92, Issue 2-3, 2006, Pages 261-266

  Williamson, Doug ^a   Brown, Eileen ^a   Perlis, Roy H ^b   Ahl, Jonna ^a   Baker, Robert W ^a   Tohen, Mauricio ^a,c  

^a ELI LILLY AND COMPANY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Bipolar I depression; Factor analysis; Olanzapine; Olanzapine fluoxetine combination

Indexed keywords

FLUOXETINE PLUS OLANZAPINE; OLANZAPINE; PLACEBO;

ARTICLE; AUTONOMIC NEUROPATHY; BIPOLAR I DISORDER; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; HUMAN; OUTCOME ASSESSMENT; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM;

BENZODIAZEPINES; BIPOLAR DISORDER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FLUOXETINE; HUMANS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33646412607     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.02.011     Document Type: Article

References (12)

1. Galinowski A., and Lehert P. Structural validity of MADRS during antidepressant treatment. Int. Clin. Psychopharmacol. 10 (1995) 157-161
2. Hamilton M. The assessment of anxiety states by rating. Br. J. Psychol. 32 (1959) 50-55
3. Khan A., Khan S.R., Shankles E.B., and Polissar N.L. Relative sensitivity of the Montgomery Åsberg Depression Rating Scale, the Hamilton Depression rating scale, and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int. Clin. Psychopharmacol. 17 (2002) 281-285
4. Kenward M.G., and Roger J.H. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53 (1997) 983-997
5. Montgomery S.A., and Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
6. Mulder R.T., Joyce P.R., and Frampton C. Relationships among measures of treatment outcome in depressed patients. J. Affect. Disord. 76 (2003) 127-135
7. Müller M.J., Himmerich H., Kienzle B., and Szegedi A. Differentiating moderate and severe depression using the Montgomery-Åsberg depression rating scale (MADRS). J. Affect. Disord. 77 (2003) 255-260
8. Parker R.D., Flint E.P., Bosworth H.B., Pieper C.F., and Steffens D.C. A three-factor analytic model of the MADRS in geriatric depression. Int. J. Geriatr. Psychiatry 18 (2003) 73-77
9. Snaith R.P. What do depression rating scales measure?. Br. J. Psychiatry 163 (1993) 293-298
10. Spearing M.K., Post P.M., Leverich G.S., Brandt D., and Nolen W. Modification of the Clinical Global Impression (CGI) scale for use in bipolar illness (BP): CGI-BP. Psychiatry Res. 73 (1997) 159-171
11. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dubé S., Tollefson G.D., and Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar depression. Arch. Gen. Psychiatry 60 (2003) 1079-1088
12. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435